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The glycan profile of therapeutic monoclonal antibodies frequently plays an important role in their biological 
function and pharmacokinetics. Therefore, improved control of the glycosylation profile of biopharmaceutical 
monoclonal antibodies has become an increased priority during late stage and commercial manufacturing of 
New Biological Entities as well as biosimilars. Two ways to obtain better control are through process parameter 
optimization and/or through addition of media supplements to the production reactor. Cell culture 
supplementation with mycophenolic acid is one method to efficiently manipulate N-glycan profiles of monoclonal 
antibodies, notably the level of fucosylation. We have observed at least for some CHO-based cell culture 
processes, that the timing of mycophenolic acid addition to the cell culture process relative to the cell growth 
profile is important to fine-tune the effect on the glycoprofile. This poster presents a case study where batch-to-
batch variation of the N-glycan content of fucose for a monoclonal antibody at harvest could be correlated to the 
mycophenolic acid dose timing relative to the viable cell volume profile measured online by use of capacitance 
probes in 15 kL large-scale manufacturing bioreactors. Scale-down runs performed at 3 L scale with different 
timing of mycophenolic acid addition supported these observations. These data demonstrates how online 
capacitance probe measurements potentially could be used to optimize the process parameter mycophenolic 
acid dose timing, and thereby, further improve control of product N-glycan profile for this process. 
